Shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report) traded up 3.1% during trading on Thursday . The company traded as high as $52.32 and last traded at $52.09. 15,949 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 34,859 shares. The stock had previously closed at $50.52.
ALPS Medical Breakthroughs ETF Stock Up 3.1%
The stock’s 50 day moving average price is $53.89 and its 200 day moving average price is $51.86.
Institutional Investors Weigh In On ALPS Medical Breakthroughs ETF
Several hedge funds and other institutional investors have recently added to or reduced their stakes in SBIO. Delta Investment Management LLC purchased a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter worth $6,112,000. Bank of America Corp DE increased its stake in ALPS Medical Breakthroughs ETF by 63.1% during the 1st quarter. Bank of America Corp DE now owns 98,679 shares of the company’s stock worth $5,165,000 after buying an additional 38,193 shares during the period. LPL Financial LLC increased its stake in ALPS Medical Breakthroughs ETF by 438.7% during the 4th quarter. LPL Financial LLC now owns 42,755 shares of the company’s stock worth $2,190,000 after buying an additional 34,819 shares during the period. Jones Financial Companies Lllp purchased a new stake in ALPS Medical Breakthroughs ETF during the 1st quarter worth $782,000. Finally, Stifel Financial Corp purchased a new stake in ALPS Medical Breakthroughs ETF during the 4th quarter worth $1,018,000.
About ALPS Medical Breakthroughs ETF
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
Featured Articles
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
